Pallasite Ventures

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Ionomr Innovations Inc. is a Canadian company specializing in the design, adaptation, and manufacture of advanced ion-exchange membranes and polymer technologies. Founded in 2013 and based in Vancouver, Ionomr is focused on providing solutions for clean technology applications, including water treatment, energy storage, and hydrogen production. Their Aemion membrane systems are notable for being alkaline-stable, highly durable, and versatile, enabling clients to improve performance while minimizing environmental impact. By replacing toxic fluorinated chemicals with eco-friendly hydrocarbon alternatives, Ionomr aims to reduce pollution and enhance the sustainability of electrochemical systems. The company also offers chemical engineering services, further supporting the integration of its innovative materials into various applications, contributing to the development of cleaner and more resilient energy solutions.

Oncoustics is a company focused on enhancing clinical workflow through advanced artificial intelligence solutions aimed at non-invasive surveillance, diagnostics, and treatment monitoring of diseases with significant unmet clinical needs. Unlike competitors that rely on image recognition, Oncoustics utilizes AI to analyze raw ultrasound signals from readily available handheld devices, allowing for the rapid differentiation between healthy and diseased tissues. This innovative approach uncovers novel acoustic biomarkers that align with existing medical standards. Initially concentrating on liver disease, a market valued at $30 billion, Oncoustics has sought Breakthrough Device Designation from the FDA for its OnX system, designed to detect liver fibrosis, with further regulatory submissions underway. The company is also developing additional liver-related products and possesses clinical data for applications in various other organ conditions, including prostate, kidney, breast, and thyroid diseases and cancers.

Zeno Power is a company that creates advanced power systems that use radioisotopes. The company intends to increase the production of small-scale nuclear batteries capable of powering spacecraft and undersea technologies for years. Zeno, founded in 2018 by three Vanderbilt University students, intends to be the first to enter the commercial market with a novel new combination of affordability and lightweight.

Ionomr Innovations Inc. is a Canadian company specializing in the design, adaptation, and manufacture of advanced ion-exchange membranes and polymer technologies. Founded in 2013 and based in Vancouver, Ionomr is focused on providing solutions for clean technology applications, including water treatment, energy storage, and hydrogen production. Their Aemion membrane systems are notable for being alkaline-stable, highly durable, and versatile, enabling clients to improve performance while minimizing environmental impact. By replacing toxic fluorinated chemicals with eco-friendly hydrocarbon alternatives, Ionomr aims to reduce pollution and enhance the sustainability of electrochemical systems. The company also offers chemical engineering services, further supporting the integration of its innovative materials into various applications, contributing to the development of cleaner and more resilient energy solutions.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

Prescryptive Health, Inc. is a digital health company that operates a prescription benefits platform aimed at enhancing the accessibility and affordability of medications for both payers and patients. Established in 2017 and based in Redmond, Washington, the company provides services that include analyzing current plan designs, recommending new plans, and facilitating member enrollment. Its platform empowers users by offering direct access to market pricing, unbiased information, and real-time cost insights regarding prescribed treatments. This includes details on insurance coverage, out-of-pocket expenses, and available lower-cost alternatives. Prescryptive Health serves a diverse range of clients, including employers, health plans, providers, pharmacies, and pharmaceutical companies, with the goal of democratizing the prescription drug market.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Ionomr Innovations Inc. is a Canadian company specializing in the design, adaptation, and manufacture of advanced ion-exchange membranes and polymer technologies. Founded in 2013 and based in Vancouver, Ionomr is focused on providing solutions for clean technology applications, including water treatment, energy storage, and hydrogen production. Their Aemion membrane systems are notable for being alkaline-stable, highly durable, and versatile, enabling clients to improve performance while minimizing environmental impact. By replacing toxic fluorinated chemicals with eco-friendly hydrocarbon alternatives, Ionomr aims to reduce pollution and enhance the sustainability of electrochemical systems. The company also offers chemical engineering services, further supporting the integration of its innovative materials into various applications, contributing to the development of cleaner and more resilient energy solutions.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

CTO.ai is a developer of serverless DevOps software that focuses on automating developer workflows. Its platform offers a framework that allows developers to discover, build, and share workflows, thereby enhancing operational efficiencies at scale. By providing an intuitive and measurable developer experience, CTO.ai aims to significantly increase productivity for development teams. The solution allows businesses to upgrade from traditional CI/CD tools to a more tailored developer control plane, enabling individual developers to work more effectively without the need for additional operational engineers.

NuCurrent, Inc. is a Chicago-based company specializing in the design, fabrication, and integration of high-efficiency wireless power antennas and surface-mount inductors. Founded in 2009, the company develops antennas for both low and high frequency systems, catering to a variety of applications such as power electronics, RF electronics, and frequency synthesis. NuCurrent's innovations adhere to industry standards set by the Alliance for Wireless Power, Wireless Power Consortium, and Power Matters Alliance. The company collaborates closely with original equipment manufacturers (OEMs) and integrators to deliver custom-designed prototypes that enhance performance while reducing costs and sizes. Its patented technologies effectively address high-frequency challenges, resulting in improved efficiency and durability for wireless power applications.

Damon Motors Inc. is a technology company focused on transforming urban mobility through innovative motorcycle design and safety features. Founded in 2017 and headquartered in Vancouver, Canada, with additional offices in San Rafael, California, Damon develops advanced systems aimed at enhancing rider safety and situational awareness. Its flagship product, the 360º Advanced Warning System, incorporates cutting-edge sensor fusion, robotics, and artificial intelligence to provide comprehensive environmental awareness for motorcyclists. The company’s proprietary electric powertrain, HyperDrive, powers motorcycles that boast impressive speed, distinctive design, and new features such as CoPilot and Shift. Damon Motors is committed to establishing a new benchmark for motorcycle safety and sustainability, successfully appealing to a new generation of riders in the United States and internationally.

Optina Diagnostics Inc. is a Canadian company focused on developing innovative technology for the early detection of Alzheimer’s disease through hyperspectral imaging of the eye. Founded in 2010 and headquartered in Montréal, the company employs advanced retinal imaging and artificial intelligence to provide non-invasive diagnostic tests for under-diagnosed diseases. Optina Diagnostics' retinal imaging test identifies key patient features that assist healthcare professionals in evaluating health status and disease risk, enabling timely and appropriate care. The company's imaging systems not only facilitate the detection of Alzheimer's-related biomarkers, such as beta-amyloid plaques, but also address other conditions like age-related macular degeneration and diabetic retinopathy. By enhancing brain health assessment, Optina Diagnostics aims to deliver critical information early in the disease progression, ultimately improving patient outcomes.

Keela is a software company that specializes in providing a comprehensive fundraising customer relationship management (CRM) solution tailored for nonprofit organizations. Its platform combines essential tools for managing donor relationships, mobilizing volunteers, and enhancing fundraising efforts. By integrating donor communications with fundraising strategies, Keela enables nonprofits to optimize their outreach through targeted, multi-channel approaches. The software allows users to access critical donor information, facilitating informed decisions about when and how to solicit donations. Additionally, Keela offers customizable data features that help organizations monitor and refine their campaigns, manage donation records, and generate custom reports for board members, ultimately streamlining workflows and enhancing operational efficiency for small and medium-sized nonprofits.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.

Dooly Research Ltd. is a Vancouver-based company that specializes in developing artificial intelligence-driven software designed to enhance the efficiency of sales teams. Founded in 2015, Dooly's platform automates the customer relationship management process by monitoring and sharing digital notes, fields, and tasks from meetings and customer interactions. This software facilitates the seamless transfer of information between team members and systems, thereby addressing the challenges of note-taking and information sharing. By organizing workflow systems in real-time, Dooly's platform enables businesses to minimize administrative tasks, allowing sales teams to concentrate on core activities essential for closing deals.

We build and maintain the website and digital marketing for your realty business, so you can stay connected with your clients—and attract new ones. As a team of marketers, engineers, and designers, we work together to give REALTORS® something they’ve never had before: The chance to market themselves online, and stand out, supported by the knowledge and tools only a team of experts can provide.

Klue is a B2B SaaS company that specializes in market and competitive intelligence, founded in 2015 by Jason Smith and Sarathy Naicker, and is based in Vancouver, Canada. The company offers a competitive enablement platform that assists sales and revenue teams in utilizing competitive intelligence to enhance their business outcomes. Klue's platform aggregates and organizes intelligence from various internal and external sources, providing actionable insights that help organizations navigate competitive environments effectively. By leveraging this curated intelligence, businesses can make informed decisions and improve their competitive positioning in the market.

ViralGains, Inc. is a video marketing platform based in Boston, Massachusetts, established in 2012. The company assists advertising agencies and brands in effectively reaching their target audiences by enhancing consumer engagement through video content distributed across various digital channels. ViralGains focuses on business-to-business initiatives, including the distribution, seeding, and marketing of viral videos. Its platform integrates videos into user experiences on diverse destinations such as blogs, social games, and social news, while also leveraging influencer partnerships. Additionally, ViralGains utilizes zero-party data through interactive ads and audience building technology, allowing brands to discover, understand, and nurture both new and returning customers effectively. The platform measures consumer interactions with video content, enabling marketers to connect with audiences in preferred venues and contexts.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Damon Motors Inc. is a technology company focused on transforming urban mobility through innovative motorcycle design and safety features. Founded in 2017 and headquartered in Vancouver, Canada, with additional offices in San Rafael, California, Damon develops advanced systems aimed at enhancing rider safety and situational awareness. Its flagship product, the 360º Advanced Warning System, incorporates cutting-edge sensor fusion, robotics, and artificial intelligence to provide comprehensive environmental awareness for motorcyclists. The company’s proprietary electric powertrain, HyperDrive, powers motorcycles that boast impressive speed, distinctive design, and new features such as CoPilot and Shift. Damon Motors is committed to establishing a new benchmark for motorcycle safety and sustainability, successfully appealing to a new generation of riders in the United States and internationally.

Blue Mesa Health Inc. is a digital therapeutics company focused on diabetes prevention through its innovative platform, Transform. Founded in 2015 and based in New York, the company provides a comprehensive solution that combines health coaching, behavioral psychology, and technology to help individuals reverse prediabetes and manage their health. Transform offers a weight loss program and weekly lessons, delivering evidence-based behavioral interventions in a flexible format. The company's mission extends beyond the United States, as it has launched its services in Latin America and the Middle East, aiming to become a global leader in culturally diverse, technology-driven health solutions. Blue Mesa Health operates as a subsidiary of Virgin Pulse, Inc.

Popular Pays, Inc. is a technology company that operates a platform designed to connect brands with content creators, facilitating the production of engaging and shareable content. Established in 2013 and headquartered in Chicago, Illinois, with an additional location in New York, Popular Pays offers a comprehensive marketplace where brands can browse, apply, and collaborate with creators. The platform features tools such as a brief builder, creator profiles, in-app messaging, and API integrations, which streamline the collaboration process and enhance communication between users. By providing powerful analytics and workflow tools, Popular Pays empowers brands to effectively manage campaigns and select the right creators to tell their stories.

Prospect Bio is a synthetic biology company based in Brisbane, California, that specializes in developing biosensors for the detection of small molecules. These biosensors utilize living cells to perform complex chemical measurements, offering a cost-effective and scalable alternative to traditional testing methods that often rely on expensive and slow laboratory equipment. By addressing the need for improved testing solutions driven by regulatory demands, quality control, and supply chain concerns, Prospect Bio aims to transform testing processes across various industries. The company collaborates with a diverse array of partners, including major players in the wine industry, agriculture, prenatal diagnostics, and biotechnology. Its innovative approach combines microbial biotechnologies with automation and computational tools, enabling rapid biosensor and pathway discovery for medical research and other applications.

Bloomlife is a pioneering women's health company focused on enhancing maternal care through innovative technology. By integrating connected devices with cloud-based data analytics, Bloomlife aims to improve access to care for expectant mothers and empower them with crucial information. The company's remote maternal care platform facilitates the monitoring of high-risk pregnancies, allowing obstetricians to better assess maternal and fetal risks and educate patients effectively. Bloomlife’s solutions reduce the need for frequent in-person appointments and lengthy referral processes, thus streamlining the management of pregnancy complications. With a commitment to redefining maternal health, Bloomlife seeks to become the leading provider of remote care for expectant women worldwide, ultimately improving health outcomes for mothers and babies.

Luxury Garage Sale is a retailer that operates both physical stores and an online e-commerce platform, specializing in the sale of luxury designer clothing, shoes, handbags, accessories, and jewelry. The company sources these items through consignment and offers them to consumers at discounted prices, providing access to high-end fashion brands at more affordable rates. Founded in 2010 and headquartered in Chicago, Illinois, Luxury Garage Sale has physical locations in Chicago, Highland Park (Illinois), and Dallas (Texas).

Routific, Inc. is a Vancouver-based company that specializes in route optimization solutions for delivery businesses. Its platform automates and enhances vehicle routing and scheduling operations, serving small and medium-sized enterprises both in Canada and internationally. Inspired by the foraging behaviors of honey bees, Routific's technology helps local delivery businesses efficiently plan routes, resulting in significant reductions in time and fuel consumption, as well as lowering carbon emissions by 20-40%. The software includes features such as intelligent route optimization, dispatch and live tracking, and delivery notifications, enabling companies to reduce delivery costs, improve driver efficiency, and enhance customer satisfaction.

ViralGains, Inc. is a video marketing platform based in Boston, Massachusetts, established in 2012. The company assists advertising agencies and brands in effectively reaching their target audiences by enhancing consumer engagement through video content distributed across various digital channels. ViralGains focuses on business-to-business initiatives, including the distribution, seeding, and marketing of viral videos. Its platform integrates videos into user experiences on diverse destinations such as blogs, social games, and social news, while also leveraging influencer partnerships. Additionally, ViralGains utilizes zero-party data through interactive ads and audience building technology, allowing brands to discover, understand, and nurture both new and returning customers effectively. The platform measures consumer interactions with video content, enabling marketers to connect with audiences in preferred venues and contexts.

Dabble Inc. is a community marketplace that enables individuals to teach, discover, and host affordable in-person classes. Founded in 2011 and based in Chicago, Illinois, Dabble caters to a diverse range of interests, offering classes in areas such as arts, culinary, fitness, technology, and entrepreneurship. The platform facilitates connections between passionate instructors and curious learners, allowing educators to list classes and reach a broader audience. This model not only provides teachers with a means to generate additional income and showcase their expertise but also offers local businesses the opportunity to host relevant classes, thereby increasing their exposure and driving customer engagement. By simplifying the process of class submission through an online portal, Dabble creates a vibrant community where learning and creativity can thrive.

RedSeal, Inc. specializes in cybersecurity analytics solutions aimed at enhancing the digital resilience of organizations and government agencies globally. Founded in 2004 and based in San Jose, California, RedSeal's platform creates detailed network models and assesses security risks, allowing users to prioritize actions for remediation. By identifying potential attack paths to critical assets, the solution helps organizations allocate their limited security resources effectively, improve incident response times, and maintain comprehensive network visibility. RedSeal's offerings support compliance with various industry regulations and standards, while its technology integrates seamlessly with leading security tools and infrastructure providers. The company serves a diverse client base, including major financial institutions, retail companies, and U.S. federal agencies. RedSeal has established partnerships with top network infrastructure suppliers and is backed by several notable venture capital firms.

Funnely is a cloud-based platform designed to assist e-commerce marketers in enhancing their Facebook and Instagram advertising campaigns through a data-driven approach. By automating the creation and optimization of advertising campaigns, Funnely enables small and medium online store owners to increase their return on investment. The platform utilizes first-party data to dynamically optimize campaigns, effectively grouping them and managing audience assignments, including exclusions to prevent overlapping target segments. This strategic approach allows businesses to lower their customer acquisition costs while boosting overall sales performance.

ViralGains, Inc. is a video marketing platform based in Boston, Massachusetts, established in 2012. The company assists advertising agencies and brands in effectively reaching their target audiences by enhancing consumer engagement through video content distributed across various digital channels. ViralGains focuses on business-to-business initiatives, including the distribution, seeding, and marketing of viral videos. Its platform integrates videos into user experiences on diverse destinations such as blogs, social games, and social news, while also leveraging influencer partnerships. Additionally, ViralGains utilizes zero-party data through interactive ads and audience building technology, allowing brands to discover, understand, and nurture both new and returning customers effectively. The platform measures consumer interactions with video content, enabling marketers to connect with audiences in preferred venues and contexts.